Immune mechanisms in hypertension and vascular injury

Clinical Science

Volumn 126, Issue 4, 2014, Pages 267-274

  Schiffrin, Ernesto L ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Aldosterone; Blood pressure; Endothelin; Inflammation; Innate and adaptive immunity; Interleukin; Regulatory t cell (Treg cell); Renin angiotensin system (ras); Target Organ Damage; Vascular Remodelling

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GALECTIN 1; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 6; NEUROPILIN 1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SODIUM CHLORIDE; STAT3 PROTEIN; TRANSCRIPTION FACTOR FOXP3;

ADAPTIVE IMMUNITY; ADOPTIVE TRANSFER; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; BLOOD PRESSURE; BLOOD VESSEL INJURY; CELL CYCLE ARREST; CYTOKINE PRODUCTION; ENDOTHELIAL DYSFUNCTION; ENZYME ACTIVITY; HUMAN; HYPERTENSION; IMMUNITY; INNATE IMMUNITY; LYMPHOCYTE FUNCTION; NONHUMAN; OBESITY; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; SALT INTAKE; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH17 CELL;

ADAPTIVE IMMUNITY; ANIMALS; CARDIOVASCULAR DISEASES; CYTOKINES; HUMANS; HYPERTENSION; INFLAMMATION; T-LYMPHOCYTE SUBSETS;

EID: 84886672246     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20130407     Document Type: Review

References (63)

1. Virdis, A. and Schiffrin, E. L. (2003) Vascular inflammation: a role in vascular disease in hypertension? Curr. Opin. Nephrol. Hypertens. 12, 181-187
2. Savoia, C. and Schiffrin, E. L. (2007) Vascular inflammation in hypertension and diabetes: molecular mechanisms and therapeutic interventions. Clin. Sci. 112, 375-384
3. Verlohren, S., Muller, D. N., Luft, F. C. and Dechend, R. (2009) Immunology in hypertension, preeclampsia, and target-organ damage. Hypertension 54, 439-443
4. Harrison, D. G., Guzik, T. J., Lob, H. E., Madhur, M. S., Marvar, P. J., Thabet, S. R., Vinh, A. and Weyand, C. M. (2011) Inflammation, immunity and hypertension. Hypertension 57, 132-140
5. Leibowitz, A. and Schiffrin, E. L. (2011) Immune mechanisms in hypertension. Curr. Hypertens. Rep. 13, 465-472
6. Taguchi, A., Sanada, M., Suei, Y., Ohtsuka, M., Lee, K., Tanimoto, K., Tsuda, M., Ohama, K., Yoshizumi, M. and Higashi, Y. (2004) Tooth loss has been associated with increased risk of incident hypertension in postmenopausal women. Hypertension 43, 1297-1300
7. Tonetti, M. S., D'Aiuto, F., Nibali, L., Donald, A., Storry, C., Parkar, M., Suvan, J., Hingorani, A. D., Vallance, P. and Deanfield, J. (2007) Treatment of periodontal disease and endothelial function. New Eng. J. Med. 356, 911-920
8. Svendsen, U. G. (1976) Evidence for an initial, thymus independent and a chronic, thymus dependent phase of DOCA and salt hypertension in mice. Acta Pathol. Microbiol. Scand. A 84, 523-528
9. Olsen, F. (1980) Transfer of arterial hypertension by splenic cells from DOCA-salt hypertensive and renal hypertensive rats to normotensive recipients. Acta Pathol. Microbiol. Scand. C 88, 1-5
10. Takeichi, N., Suzuki, K., Okayasu, T. and Kobayashi, H. (1980) Immunological depression in spontaneously hypertensive rats. Clin. Exp. Immunol. 40, 120-126
11. Rodriguez-Iturbe, B., Pons, H., Quiroz, Y., Gordon, K., Rincsṕon, J., Ch́avez, M., Parra, G., Herrera-Acosta, J., Ǵomez-Garre, D., Largo, R. et al. (2001) Mycophenolate mofetil prevents salt-sensitive hypertension resulting from angiotensin II exposure. Kidney Int. 59, 2222-2232
12. Crowley, S. D., Frey, C. W., Gould, S. K., Griffiths, R., Ruiz, P., Burchette, J. L., Howell, D. N., Makhanova, N., Yan, M., Kim, H. S. et al. (2008) Stimulation of lymphocyte responses by angiotensin II promotes kidney injury in hypertension. Am. J. Physiol. 295, F515-F524
13. De Ciuceis, C., Amiri, F., Brassard, P., Endemann, D. H., Touyz, R. M. and Schiffrin, E. L. (2005) Reduced vascular remodeling, endothelial dysfunction, and oxidative stress in resistance arteries of angiotensin II-infused macrophage colony-stimulating factor-deficient mice: evidence for a role in inflammation in angiotensin-induced vascular injury. Arterioscler. Thromb. Vasc. Biol. 25, 2106-2113
14. Ko, E. A., Amiri, F., Pandey, N. R., Touyz, R. M. and Schiffrin, E. L. (2007) Resistance artery remodeling in deoxycorticosterone acetate-salt hypertension is dependent on vascular inflammation: evidence from m-csf deficient mice. Am. J. Physiol. 292, H1789-H1795
15. Liu, J., Yang, F., Yang, X. P., Jankowski, M. and Pagano, P. J. (2003) NAD(P)H oxidase mediates angiotensin II-induced vascular macrophage infiltration and medial hypertrophy. Arterioscler. Thromb. Vasc. Biol. 23, 776-782
16. Wenzel, P., Knorr, M., Kossmann, S., Stratmann, J., Hausding, M., Schuhmacher, S., Karbach, S. H., Schwenk, M., Yogev, N., Schulz, E. et al. (2011) Lysozyme M-positive monocytes mediate angiotensin II-induced arterial hypertension and vascular dysfunction. Circulation 124, 1370-1381
17. Shao, J., Nangaku, M., Miyata, T., Inagi, R., Yamada, K., Kurokawa, K. and Fujita, T. (2003) Imbalance of T-cell subsets in angiotensin II-infused hypertensive rats with kidney injury. Hypertension 42, 31-38
18. Guzik, T. J., Hoch, N. E., Brown, K. A., McCann, L. A., Rahman, A., Dikalov, S., Goronzy, J., Weyand, C. and Harrison, D. G. (2007) Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. J. Exp. Med. 204, 2449-2460
19. Gratze, P., Dechend, R., Stocker, C., Park, J.-K., Feldt, S., Shagdarsuren, E., Wellner, M., Gueler, F., Rong, S., Gross, V. et al. (2008) Novel role for inhibitor of differentiation 2 in the genesis of angiotensin II-induced hypertension. Circulation 117, 2645-2656
20. Madhur, M., Lob, H. E., McCann, L. A., Iwakura, Y., Blinder, Y., Guzik, T. J. and Harrison, D. G. (2010) Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction. Hypertension 55, 500-505
21. Senchenkova, E. Y., Russell, J., Kurmaeva, E., Ostanin, D. and Granger, D. N. (2011) Role of T lymphocytes in angiotensin II-mediated microvascular thrombosis. Hypertension 58, 959-965
22. Armstrong, A. W., Harskamp, C. T. and Armstrong, E. J. (2013) The association between psoriasis and hypertension: a systematic review and meta-analysis of observational studies. J. Hypertens. 31, 433-443
23. Lob, H. E., Marvar, P. J., Guzik, T. J., Sharma, S., McCann, L. A., Weyand, C., Gordon, F. J. and Harrison, D. G. (2010) Induction of hypertension and peripheral inflammation by reduction of extracellular superoxide dismutase in the central nervous system. Hypertension 55, 277-283
24. Schiffrin, E. L. (2012) Vascular remodeling in hypertension: mechanisms and treatment. Hypertension 59, 367-374
25. Crowley, S. D., Song, Y., Lin, E. E., Griffiths, R., Kim, H. and Ruiz, P. (2010) Lymphocyte responses exacerbate angiotensin II-dependent hypertension. Am. J. Physiol. 298, R1089-R1097
26. De Miguel, C., Lund, H. and Mattson, D. (2011) High dietary protein exacerbates hypertension and renal damage in Dahl SS rats by increasing infiltrating immune cells in the kidney. Hypertension 57, 269-274
27. Bu, D. X. and Lichtman, A. H. (2010) T cells and blood vessels: costimulation turns up the pressure. Circulation 122, 2495-2498
28. Vinh, A., Chen, W., Blinder, Y., Weiss, D., Taylor, W. R., Goronzy, J. J., Weyand, C. M., Harrison, D. G. and Guzik, T. J. (2010) Inhibition and genetic ablation of the B7/CD28 T-cell costimulation axis prevents experimental hypertension. Circulation 122, 2529-2537
29. Kent, W. J., Sugnet, C. W., Furey, T. S., Roskin, K. M., Pringle, T. H., Zahler, A. M. and Haussler, D. (2002) The human genome browser at UCSC. Genome Res. 12, 996-1006
30. Cowley, Jr, A. W., Liang, M., Roman, R. J., Greene, A. S. and Jacob, H. J. (2004) Consomic rat model systems for physiological genomics. Acta Physiol. Scand. 181, 585-592
31. Viel, E. C., Lemaríe, C. A., Benkirane, K., Paradis, P. and Schiffrin, E. L. (2010) Immune regulation and vascular inflammation in genetic hypertension. Am. J. Physiol. 298, H938-H944
32. Barhoumi, T., Kasal, D. A. B., Li, M. W., Shbat, L., Laurant, P., Fritsch Neves, M., Paradis, P. and Schiffrin, E. L. (2011) T regulatory lymphocytes prevent angiotensin II-induced hypertension and vascular injury. Hypertension 57, 469-476
33. Kvakan, H., Kleinewietfeld, M., Qadri, F., Park, J. K., Fischer, R., Schwarz, I., Rahn, H. P., Plehm, R., Wellner, M., Elitok, S. et al. (2009) Regulatory T cells ameliorate angiotensin II-induced cardiac damage. Circulation 119, 2904-2912
34. Kasal, D. A. B., Barhoumi, T., Li, M. W., Fritsch Neves, M., Laurant, P., Paradis, P. and Schiffrin, E. L. (2012) T regulatory lymphocytes prevent aldosterone-induced vascular injury. Hypertension 59, 324-330
35. Galkina, E., Harry, B. L., Ludwig, A., Liehn, E. A., Sanders, J. M., Bruce, A., Weber, C. and Ley, K. (2007) CXCR6 promotes atherosclerosis by supporting T-cell homing, interferon-γ production, and macrophage accumulation in the aortic wall. Circulation 116, 1801-1811
36. Mallat, Z., Ait-Oufella, H. and Tedgui, A. (2005) Regulatory T cell responses: potential role in the control of atherosclerosis. Curr. Opin. Lipidol. 16, 518-524
37. Ait-Oufella, H., Salomon, B. L., Potteaux, S., Robertson, A.-K. L., Gourdy, P., Zoll, J., Merval, R., Esposito, B., Cohen, J. L., Fisson, S. et al. (2006) Natural regulatory cells control the development of atherosclerosis in mice. Nat. Med. 12, 178-180
38. Valaperti, A., Marty, R. R., Kania, G., Germano, D., Mauermann, N., Dirnhofer, S., Leimenstoll, B., Blyszczuk, P., Dong, C., Mueller, C. et al. (2008) CD11b+ monocytes abrogate Th17 CD4+ T cell-mediated experimental autoimmune myocarditis. J. Immunol. 180, 2686-2695
39. Vignali, D. A., Collison, L. W. and Workman, C. J. (2008) How regulatory T cells work. Nat. Rev. Immunol. 8, 523-532
40. Watanabe, K., Rao, V. P., Poutahidis, T., Rickman, B. H., Ohtani, M., Xu, S., Rogers, A. B., Ge, Z., Horwitz, B. H., Fujioka, T. et al. (2008) CTLA-4 blockade abrogates protection by regulatory T cells in a mouse model of microbially-induced innate immune-driven colitis. Infect. Immun. 76, 5834-5842
41. Kobie, J. J., Shah, P. R., Yang, L., Rebhahn, J. A., Fowell, D. J. and Mosmann, T. R. (2006) T regulatory and primed uncommitted CD4 T cells express CD73, which suppresses effector CD4 T cells by converting 5_-adenosine monophosphate to adenosine. J. Immunol. 177, 6780-6786
42. Shevach, E. M. (2009) Mechanisms of Foxp3+ T regulatory cell-mediated suppression. Immunity 30, 636-645
43. Donnelly, R. P., Dickensheets, H. and Finbloom, D. S. (1999) The interleukin-10 signal transduction pathway and regulation of gene expression in mononuclear phagocytes. Interferon Cytokine Res. 19, 563-573
44. Strle, K., Zhou, J. H., Broussard, S. R., Venters, H. D., Johnson, R. W., Freund, G. G., Dantzer, R. and Kelley, K. W. (2002) IL-10 promotes survival of microglia without activating Akt. J. Neuroimmunol. 122, 9-19
45. Kontoyiannis, D., Kotlyarov, A., Carballo, E., Alexopoulou, L., Blackshear, P. J., Gaestel, M., Davis, R., Flavell, R. and Kollias, G. (2001) Interleukin-10 targets p38 MAPK to modulate ARE-dependent TNF mRNA translation and limit intestinal pathology. EMBO J. 20, 3760-3770
46. Lee, T.-S. and Chau, L.-Y. (2002) Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice. Nat. Med. 8, 240-246
47. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 188, 287-296
48. Garin, M. I., Chu, C.-C., Golshayan, D., Cemuda-Morollon, E., Wait, R. and Lechler, R. I. (2007) Galectin-1: a key effector of regulation mediated by CD4+ CD25+ T cells. Blood 109, 2058-2065
49. Grossman, W. J., Verbsky, J. W., Barchet, W., Colonna, M., Atkinson, J. P. and Ley, T. J. (2004) Human T regulatory cells can use the perforin pathway to cause autologous target cell death. Immunity 21, 589-601
50. Gondek, D. C., Lu, L.-F., Quezada, S. A., Sakaguchi, S. and Noelle, R. J. (2005) Cutting edge: contact-mediated suppression by CD4+ CD25+ regulatory cells involves a granzyme B-dependent, perforin-independent mechanism. J. Immunol. 174, 1783-1786
51. Misra, N., Bayry, J., Lacroix-Desmazes, S., Kazatchkine, M. D. and Kaveri, S. V. (2004) Cutting edge: human CD4+ CD25+ T cells restrain the maturation and antigen-presenting function of dendritic cells. J. Immunol. 172, 4676-4680
52. Onishi, Y., Fehervari, Z., Yamaguchi, T. and Sakaguchi, S. (2008) Foxp3+ natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation. Proc. Natl. Acad. Sci. U.S.A. 105, 10113-10118
53. Deaglio, S., Dwyer, K. M., Gao, W., Friedman, D., Asheva, A., Erat, A., Chen, J.-F., Enjypoji, E., Linden, J., Oukka, M. et al. (2007) Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J. Exp. Med. 204, 1257-1265
54. Shalev, I., Liu, H., Koscik, C., Bartczak, A., Javadi, M., Wong, K. M., Maknojia, A., He, W., Liu, M. F., Diao, J. et al. (2008) Targeted deletion of fgl2 leads to impaired regulatory T cell activity and development of autoimmune glomerulonephritis. J. Immunol. 180, 249-260
55. Didion, S. P., Kinzenbaw, D. A., Schrader, L. I., Chu, Y. and Faraci, F. M. (2009) Endogenous interleukin-10 inhibits angiotensin II-induced vascular dysfunction. Hypertension 54, 619-624
56. Kassan, M., Galan, M., Partyka, M., Trebak, M. and Matrougui, K. (2011) Interleukin-10 Released by CD4+ CD25+ natural regulatory T cells improves activity in hypertensive mice microvascular endothelial function through inhibition of NADPH oxidase. Arterioscler. Thromb. Vasc. Biol. 31, 2534-2542
57. Ridker, P. M., Buring, J. E., Shih, J., Matias, M. and Hennekens, C. H. (1998) Prospective study of C-reactive protein and the risk of future cardiovascular events in apparently healthy women. Circulation 98, 731-733
58. Blake, J. H., Rifai, N., Buring, J. E. and Ridker, P. M. (2003) Blood pressure, C-reactive protein, and risk of future cardiovascular events. Circulation 108, 2993-2999
59. Ammirati, E., Cianflone, D., Vecchio, V., Banfi, M., Vermi, A. C., De Metrio, M., Grigore, L., Pellegatta, F., Pirillo, A., Garlaschelli, K. et al. (2012) Effector memory T cells are associated with atherosclerosis in humans and animal models. J. Am. Heart Assoc. 1, 27-41
60. Subramanian, S., Tawakol, A., Burdo, T. H., Abbara, S., Wei, J., Vijayakumar, J., Corsini, E., Abdelbaky, A., Zanni, M. V., Hoffmann, U. et al. (2012) Arterial inflammation in patients With HIV. JAMA, J. Am. Med. Assoc. 308, 379-386
61. Schillaci, G., Maggi, P., Madeddu, G., Pucci, G., Mazzotta, E., Penco, G., Orofino, G., Menzaghi, B., Rusconi, S., Carenzi, L. et al. (2013) Symmetric ambulatory arterial stiffness index and 24-h pulse pressure in HIV infection: results of a nationwide cross-sectional study. J. Hypertens. 31, 560-567
62. Roullet, J. B., Xue, H., McCarron, D. A., Holcomb, S. and Bennett, W. M. (1994) Vascular mechanisms of cyclosporininduced hypertension in the rat. J. Clin. Invest. 93, 2244-2250
63. Youn, J.-C., Yu, H. T., Lim, B. J., Koh, M. J., Lee, J., Chang, D.-Y., Choi, Y. S., Lee, S.-H., Kang, S.-M., Jang, Y. et al. (2013) Immunosenescent CD8+ T cells and C-X-C chemokine receptor type 3 chemokines are increased in human hypertension. Hypertension 62, 126-133